Codexis outlines $72M–$76M 2026 revenue target as ECO Synthesis gains momentum and CDMO partnerships expand [Seeking Alpha]
Codexis, Inc. (CDXS)
Last codexis, inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.codexis.com/investors
Company Research
Source: Seeking Alpha
CEO Alison Moore stated that Codexis is now focused on RNA medicine and has developed the ECO Synthesis manufacturing platform to address challenges in current siRNA production technology. Moore highlighted, "We reached an Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up Quick Insights Codexis achieved a technical milestone with a 10-gram siRNA synthesis, showed high product quality, and is scaling production up to 100 grams and aiming for larger, kilogram-scale batches; analysts recognize successful scaling as crucial for commercial success. Revenue growth will be driven by contract wins with major CDMO partners, expanded use of the ECO Synthesis platform, an improved product gross margin, stable biocatalysis business, and a solid customer pipeline; much of the anticipated revenue is expected in the second half of the year. Key risks include the challenge of scalin
Show less
Read more
Impact Snapshot
Event Time:
CDXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDXS alerts
High impacting Codexis, Inc. news events
Weekly update
A roundup of the hottest topics
CDXS
News
- Codexis (CDXS) Is Up 30.9% After Returning To Q4 Profitability And Issuing 2026 Revenue Guidance [Yahoo! Finance]Yahoo! Finance
- Codexis, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform [Seeking Alpha]Seeking Alpha
- Codexis (CDXS) was given a new $5.00 price target by Stifel Nicolaus.MarketBeat
- Codexis (CDXS) had its "overweight" rating reaffirmed by Cantor Fitzgerald.MarketBeat
CDXS
Earnings
- 3/11/26 - Beat
CDXS
Analyst Actions
- 3/12/26 - Cantor Fitzgerald
CDXS
Sec Filings
- 3/11/26 - Form 10-K
- 3/11/26 - Form 8-K
- 3/11/26 - Form SCHEDULE
- CDXS's page on the SEC website